Physician profile
Michael Gitlin
NPI 1912051236
$4,027.47
in general payments reported to CMS, 2019-2025
14 companies · $823 in 2025
The $823 reported for 2025 was more than what 94% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $122 · 2021: $134 · 2022: $179 · 2023: $1,489 · 2024: $1,134 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,821 · Education: $464 · Gift: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,820.80 |
| Education | $463.54 |
| Gift | $161.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,269.36 | 2019-2025 | Implant Dentistry, Cerec |
| Straumann USA LLC | $685.98 | 2024-2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $670.34 | 2020-2024 | Arestin, Ossix Plus |
| Align Technology, INC. | $93.90 | 2025 | Invisalign |
| Dentsply Ih INC. | $60.00 | 2019 | |
| Envista Holdings Corporation | $36.31 | 2025 | Maxcem Elite |
| Kettenbach Lp | $33.74 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $31.05 | 2025 | |
| Hu-Friedy Mfg. Co., LLC | $30.62 | 2024 | |
| Geistlich Pharma, North America, INC. | $28.90 | 2025 | Biomaterials |
| Pacira Pharmaceuticals Incorporated | $28.81 | 2024 | Exparel |
| Philips North America LLC | $27.86 | 2021-2025 | Whitening Pens |
| 3m Company | $16.78 | 2022 | |
| Biohorizons Implant Systems INC. | $13.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gitlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.